Skip to main content

Biologics

Biologics

Biotherapeutic for Systemic Sclerosis

Dual MIF - D-DT Targeting to Enhance Immunotherapy Responses

Novel Peptides for the Treatment of Peripheral Arterial Disease

Luna Bioscience, Inc

Rosevix (Rosziqumab) A ROS1 Biologic for Invasive Cancers

Targeting thromboangioplasticity in tissue injury and ischemia

TargetSite Therapeutics

A new version of CAR with improved antigen sensitivity

Engineering Beta Cells for Resistance to Immune Attack and Reversal of Diabetes

Subscribe to Biologics